In this issue:
– Dietary sodium and fluid intake in HF
– The tricuspid valve: Pathology, imaging, and current treatment options
– Chronic RHF and TR
– IV iron therapy in patients with HF and iron deficiency
– Diagnosing and managing CS
– Patient-centred adult cardiovascular care
– Overcoming clinical inertia with SGLT2 inhibitors
– Chronic HF treatment
– Newly diagnosed systemic light chain amyloidosis
– Changes to the prescription process from 1 July 2024
– Medicines Repurposing Program established
– ACHD Workforce Global Survey
– COVID-19 resources
– Conferences, workshops and CPD